|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1800 Grant Street |
Address2 | Suite 800 |
| City | DENVER |
State | CO |
Zip Code | 80203 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 39371-12
|
||||||||
|
6. House ID# 334500000
|
||||||||
| TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Todd Saliman |
Date | 7/20/2021 8:19:05 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Expressed support for dear colleagues for NIH, VA, AHRQ, Assistive Tech Act, NIOSH, ASPR Trauma Center Grants, HRSA Title VII And Title VIII, HRSA Public Health and Preventive Medicine line item
Expressed support for congressionally directed spending requests in the ED FIPSE account, NIST Construction of Research Facilities account, and HRSA Program Management account
Expressed support for DOEs Office of Science
Expressed support for quantum information science research at NSF, DOE and NIST
Expressed support for the National Endowment for the Humanities and the National Archives and Records Administration
Expressed support for the USGS Climate Adaptation Science Centers
Expressed support for the Joint Fire Science Program
Expressed support for DoD basic research
Expressed support for the Pell Grant
Expressed support for NIST extramural construction grants
Expressed support for NOAA climate research programs
Expressed support for the National Space Grant Program
Expressed support for Title VI (international education programs)
Expressed support for DOD University Space Consortium
Expressed support for increased funding for the National Institutes of Health (NIH)
Expressed support for increased funding for HRSA Title VII and Title VIII
Expressed support for the CDCs National Institute for Occupational Safety and Health (NIOSH)
Expressed support for Assistive Technology Act funding
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institute of Standards & Technology (NIST)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kent |
Springfield |
|
|
|
Jack |
Waldorf |
|
|
|
Heather |
Bene |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Expressed support for continuing the NIHs National COVID Cohort Collaborative (N3C)
Discussed the formation of NIHs Advanced Research Projects Agency for Health (ARPA-H)
Expressed support for funding the FDA Center for Biologics Evaluation and Research
Expressed support for the Research Investment to Spark Economic Growth (RISE Act) (H.R. 869/S.289)
Expressed supported for value-based reimbursement for prescription drugs
Request support for funding for minimum reimbursement for osteoporosis screening under Medicare Part B. (Lynch)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kent |
Springfield |
|
|
|
Jack |
Waldorf |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Expressed support for the Research Investment to Spark Economic Growth (RISE Act) (H.R. 869/S.289)
Expressed support for the Endless Frontier Act/United States Innovation and Competition Act (S.1260)
Expressed concern over proposed amendments to S. 1260 related to research security and new conditions on NSF grant funding
Expressed support for NSF, including the Graduate Research Fellowship Program
Expressed support for federal programs that support quantum information science and technology
Expressed support for wildfire science and coordination
Expressed support for NSF for the Future Act (H.R. 2225)
Expressed support for DOE Science for the Future Act (H.R. 3593)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Heather |
Bene |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
CU signed Amicus Brief filed in support of Optional Practical Training
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Heather |
Bene |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |